Cardinal Health, Inc. $CAH Stock Holdings Lessened by Sound Financial Strategies Group LLC

Sound Financial Strategies Group LLC reduced its holdings in Cardinal Health, Inc. (NYSE:CAHFree Report) by 76.7% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 1,027 shares of the company’s stock after selling 3,390 shares during the quarter. Sound Financial Strategies Group LLC’s holdings in Cardinal Health were worth $211,000 as of its most recent filing with the SEC.

A number of other large investors also recently modified their holdings of CAH. Wellington Management Group LLP lifted its position in shares of Cardinal Health by 153.2% in the 3rd quarter. Wellington Management Group LLP now owns 5,804,090 shares of the company’s stock worth $911,010,000 after buying an additional 3,511,579 shares during the last quarter. Holocene Advisors LP lifted its position in shares of Cardinal Health by 141.4% in the 3rd quarter. Holocene Advisors LP now owns 1,926,170 shares of the company’s stock worth $302,332,000 after buying an additional 1,128,358 shares during the last quarter. Barclays PLC lifted its position in shares of Cardinal Health by 109.3% in the 3rd quarter. Barclays PLC now owns 1,584,214 shares of the company’s stock worth $248,658,000 after buying an additional 827,446 shares during the last quarter. SG Americas Securities LLC lifted its position in shares of Cardinal Health by 3,829.1% in the 4th quarter. SG Americas Securities LLC now owns 727,511 shares of the company’s stock worth $149,504,000 after buying an additional 708,995 shares during the last quarter. Finally, Victory Capital Management Inc. lifted its position in shares of Cardinal Health by 44.9% in the 3rd quarter. Victory Capital Management Inc. now owns 2,284,115 shares of the company’s stock worth $352,165,000 after buying an additional 707,495 shares during the last quarter. 87.17% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

CAH has been the topic of a number of recent research reports. Leerink Partners restated an “outperform” rating and issued a $275.00 price target on shares of Cardinal Health in a research report on Monday, March 9th. Jefferies Financial Group raised their price target on shares of Cardinal Health from $220.00 to $270.00 and gave the stock a “buy” rating in a research report on Thursday, January 22nd. JPMorgan Chase & Co. cut their price objective on shares of Cardinal Health from $243.00 to $215.00 and set a “neutral” rating on the stock in a research report on Monday, May 4th. Mizuho lifted their price objective on shares of Cardinal Health from $222.00 to $235.00 and gave the company an “outperform” rating in a research report on Friday, February 6th. Finally, Zacks Research upgraded shares of Cardinal Health from a “hold” rating to a “strong-buy” rating in a research report on Thursday, February 12th. One research analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and two have issued a Hold rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $241.80.

Check Out Our Latest Analysis on Cardinal Health

Cardinal Health Trading Down 0.7%

Cardinal Health stock opened at $183.97 on Friday. The stock has a market cap of $43.09 billion, a price-to-earnings ratio of 28.13, a PEG ratio of 1.10 and a beta of 0.53. The company’s 50-day moving average price is $211.71 and its two-hundred day moving average price is $206.94. Cardinal Health, Inc. has a 52 week low of $137.75 and a 52 week high of $233.60.

Cardinal Health (NYSE:CAHGet Free Report) last released its earnings results on Thursday, April 30th. The company reported $3.17 EPS for the quarter, beating the consensus estimate of $2.79 by $0.38. The firm had revenue of $60.94 billion for the quarter, compared to analysts’ expectations of $62.10 billion. Cardinal Health had a net margin of 0.62% and a negative return on equity of 92.61%. Cardinal Health’s quarterly revenue was up 11.0% on a year-over-year basis. During the same quarter last year, the company earned $2.35 EPS. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. Research analysts expect that Cardinal Health, Inc. will post 10.76 earnings per share for the current fiscal year.

Cardinal Health Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, July 15th. Shareholders of record on Wednesday, July 1st will be paid a dividend of $0.5158 per share. This represents a $2.06 annualized dividend and a yield of 1.1%. The ex-dividend date of this dividend is Wednesday, July 1st. This is a positive change from Cardinal Health’s previous quarterly dividend of $0.51. Cardinal Health’s dividend payout ratio is 31.19%.

Cardinal Health Company Profile

(Free Report)

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.

Featured Articles

Institutional Ownership by Quarter for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.